1-(azetidin-3-yl)-2-methyl-1H-imidazole dihydrochloride, 95.0%, 500mg

2-Amino-1-methoxybutane, 90.0%, 25ml

CEFOTETAN, 95%, 25mg

N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]piperidine-4-carboxamide dihydrochloride, 95.0%, 500mg

2-((Benzyloxy)methyl)oxirane, 95.0%, 25g

oxo(1,3-thiazol-2-ylamino)acetic acid, 95.0%, 1g

L(+)-ascorbic acid, min. 99%, pa, 100 g, plastic packaging.

Hippuric acid sodium salt, min. 99%, cryst., 25 g, plastic packaging.

N-methyl-N-((3R,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine compound with N-methyl-N-((3S,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine(1:1), 98%, 10mg

tert-Butyl 1H-pyrazole-4-carboxylate, 97.0%, 5g

2-Chloro-3-methylisonicotinonitrile, 95.0%, 250mg

Ethyl 5-bromo-4-methylthiazole-2-carboxylate, 95%, 1g

5-Chloro-2-tetrazol-1-yl-benzaldehyde, 95.0%, 100mg